Biography
Dr. Rohan is a Professor in the Department of Pharmaceutical Sciences in the School of Pharmacy. She also holds appointments in the Department of Obstetrics, Gynecology, and Reproductive Sciences in the School of Medicine and the Clinical Translational Science Institute at the University of Pittsburgh. Additionally, she is an Investigator at the Magee-Womens Research Institute (MWRI). She obtained a Bachelor of Science in Chemical Engineering, PhD in Pharmaceutical Sciences and completed a Postdoctoral Fellowship in Mucosal Immunology. With over 35 years of experience in pharmaceutical product development, including several years in the pharmaceutical industry, her current research focuses on the areas of women’s health, infectious diseases, and global health needs. Her laboratory is dedicated to "transforming global and women’s health through pharmaceutical innovation," and her team has successfully developed over 50 pharmaceutical products, with 13 of them translated from the bench to the clinic.
Education / Training
- BS Chemical Engineering
- PhD Pharmaceutical Sciences
Research Interests
Drug Discovery and DevelopmentClinical Pharmaceutical SciencesDrug Formulations and DeliveryIn the News
Lisa Rohan selected as a recipient of the 2026 Provost's Award for Excellence in Doctoral Mentoring
Dr. Lisa Rohan, Professor in the Department of Pharmaceutical Sciences, has been selected as a recipient of the 2026 Provost’s...
Students present at annual PSRS at West Virginia University
Pitt Pharmacy graduate students from Dr. Kerry Empey’s lab (photo on right) presented their research posters on Saturday at the...
Congratulations to Dr. An Le on his successful PhD defense!
Congratulations to An Le on successfully defending his dissertation, “Understanding Biological Factors Affecting Drug Distribution in Mucosal Tissue Using in...
Featured Publications
Expanding the gene expression profiling of drug transporters and drug-metabolizing enzymes to include the upper female reproductive tract
Pharmaceutics. 2026 May 21;18(5):629. DOI: 10.3390/pharmaceutics18050629. PMID: 42198321.
In vitro pharmacokinetic properties of MK-2048, a potent drug candidate for HIV prevention
Viruses. 2026 May 15;18(5):561. DOI: 10.3390/v18050561. PMID: 42198764.
Pharmacokinetics and preliminary data on safety of meloxicam subcutaneous extended-release formulation in Sprague-Dawley rats
Front Vet Sci. 2026 Feb 20;13:1686805. DOI: 10.3389/fvets.2026.1686805. PMID: 41800314.
